Teva Pharmaceutical Industries Limited American Depositary Shares Earnings Dividend

Teva Pharmaceutical Industries Limited American Depositary Shares’s revenue jumped 2.31% since last year same period to $3981Mn in the Q1 2026. On a quarterly growth basis, Teva Pharmaceutical Industries Limited American Depositary Shares has generated -15.5% fall in its revenue since last 3-months.

Teva Pharmaceutical Industries Limited American Depositary Shares’s net profit jumped 72.43% since last year same period to $369Mn in the Q1 2026. On a quarterly growth basis, Teva Pharmaceutical Industries Limited American Depositary Shares has generated -23.13% fall in its net profits since last 3-months.

Teva Pharmaceutical Industries Limited American Depositary Shares’s net profit margin jumped 68.53% since last year same period to 9.27% in the Q1 2026. On a quarterly growth basis, Teva Pharmaceutical Industries Limited American Depositary Shares has generated -9.03% fall in its net profit margins since last 3-months.

Teva Pharmaceutical Industries Limited American Depositary Shares’s price-to-earnings ratio after this Q1 2026 earnings stands at 25.79.

Teva Pharmaceutical Industries Limited American Depositary Shares’s earning per share (EPS) estimates for the current quarter stand at 0.56 - a 21.74% jump from last quarter’s estimates.

Teva Pharmaceutical Industries Limited American Depositary Shares’s earning per share (EPS) estimates for the current year stand at 0.56.

Teva Pharmaceutical Industries Limited American Depositary Shares’s earning per share (EPS) jumped 1.92% since last year same period to 0.53 in the Q1 2026. This indicates that the Teva Pharmaceutical Industries Limited American Depositary Shares has generated 1.92% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Teva Pharmaceutical Industries Limited American Depositary Shares’s return on assets (ROA) stands at 0.06.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Teva Pharmaceutical Industries Limited American Depositary Shares’s return on equity (ROE) stands at 0.22.